Whitehawk Therapeutics Inc (WHWK)
[[ item.lastPrice ]] [[ item.priceChange ]] ([[ item.percentChange ]]) [[ item.tradeTime ]] [NASDAQ]
[[ item.bidPrice ]] x [[ item.bidSize ]] [[ item.askPrice ]] x [[ item.askSize ]]
[[ session ]] by (Cboe BZX)
[[ item.lastPrice ]] [[ item.priceChange ]] ([[ item.percentChange ]]) [[ item.tradeTime ]] [NASDAQ]
[[ item.bidPrice ]] x [[ item.bidSize ]] [[ item.askPrice ]] x [[ item.askSize ]]
[[ session ]] [[ item.lastPriceExt ]] [[ item.priceChangeExt ]] ([[ item.percentChangeExt ]]) [[ item.tradeTimeExt ]]
for [[ item.sessionDateDisplayLong ]]
Fiscal Year End Date: 12/31
| 03-2017 | 12-2016 | 09-2016 | 06-2016 | 03-2016 | |
| Cash Flows From Operating Activities | |||||
| Net Income | -4,996 | -16,984 | -13,466 | -8,580 | -4,195 |
| Depreciation Amortization | 89 | 258 | 172 | 97 | 17 |
| Accounts receivable | -28 | 114 | 109 | 114 | 64 |
| Other Working Capital | 617 | 516 | 1 | 303 | 180 |
| Other Operating Activity | 389 | 377 | 507 | 221 | 62 |
| Operating Cash Flow | $-3,929 | $-15,718 | $-12,676 | $-7,845 | $-3,873 |
| Cash Flows From Investing Activities | |||||
| PPE Investments | -2 | -113 | -113 | -113 | -110 |
| Investing Cash Flow | $-2 | $-113 | $-113 | $-113 | $-110 |
| Cash Flows From Financing Activities | |||||
| Debt Issued | 297 | 12,542 | 9,073 | 4,537 | N/A |
| Common Stock Issued | 40,248 | 19 | 19 | 19 | N/A |
| Other Financing Activity | -3,085 | -264 | -138 | -138 | 0 |
| Financing Cash Flow | $37,461 | $12,297 | $8,954 | $4,417 | $N/A |
| Beginning Cash Position | 1,610 | 5,144 | 5,144 | 5,144 | 5,144 |
| End Cash Position | 35,139 | 1,610 | 1,308 | 1,603 | 1,161 |
| Net Cash Flow | $33,529 | $-3,535 | $-3,836 | $-3,542 | $-3,984 |
| Free Cash Flow | |||||
| Operating Cash Flow | -3,929 | -15,718 | -12,676 | -7,845 | -3,873 |
| Capital Expenditure | -2 | -113 | -113 | -113 | -110 |
| Free Cash Flow | -3,931 | -15,831 | -12,790 | -7,959 | -3,984 |